Literature DB >> 1704409

Purification of El Tor cholera enterotoxins and comparisons with classical toxin.

R S Dubey1, M Lindblad, J Holmgren.   

Abstract

In 55 clinical isolates of Vibrio cholerae biotype El Tor, cholera toxin (CT) production was higher after growth in liquid medium first under relatively anaerobic conditions followed by excessive aeration (AKI conditions) as compared with growth under the optimal conditions for CT production from V. cholerae of classical biotype (median toxin level being 400 ng ml-1 and 1 ng ml-1 respectively, for the two different growth conditions). Large growth volumes further enhanced El Tor toxin production to levels at or above 3-5 micrograms ml-1 from several strains, which allowed for easy purification of toxin by salt precipitation, aluminium hydroxide adsorption and/or GM1 ganglioside affinity chromatography. However, such purified El Tor CT completely lacked the A subunit when examined by SDS-PAGE or by monoclonal anti-A subunit antibody GM1-ELISA. In contrast, when El Tor CT was prepared from bacteria grown in the presence of specific antiserum against soluble haemagglutinin/protease it contained the A subunit (unnicked) in the same proportion to the B subunit (1A:5B) as classical CT. Immunodiffusion-in-gel tests revealed that the B subunits of El Tor and classical CTs share major epitopes but also have one or more weaker biotype-specific epitopes. The two types of toxin were practically indistinguishable in various GM1-ELISA tests, and antisera raised against El Tor and classical CT, respectively, could also completely neutralize the heterologous as well as the homologous toxin activity in vivo. The results indicate that CTs from El Tor and classical V. cholerae, despite demonstrable epitope differences, are predominantly cross-reactive and give rise to antisera with strong cross-neutralizing activity.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1704409     DOI: 10.1099/00221287-136-9-1839

Source DB:  PubMed          Journal:  J Gen Microbiol        ISSN: 0022-1287


  12 in total

1.  Transient transcriptional activation of the Vibrio cholerae El Tor virulence regulator toxT in response to culture conditions.

Authors:  A I Medrano; V J DiRita; G Castillo; J Sanchez
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

2.  Purification and characterization of a cytotonic protein expressed In vitro by the live cholera vaccine candidate CVD 103-HgR.

Authors:  V Sathyamoorthy; R H Hall; B A McCardell; M H Kothary; S J Ahn; S Ratnayake
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

3.  Use of automated sequencing of polymerase chain reaction-generated amplicons to identify three types of cholera toxin subunit B in Vibrio cholerae O1 strains.

Authors:  O Olsvik; J Wahlberg; B Petterson; M Uhlén; T Popovic; I K Wachsmuth; P I Fields
Journal:  J Clin Microbiol       Date:  1993-01       Impact factor: 5.948

Review 4.  Cholera.

Authors:  J B Kaper; J G Morris; M M Levine
Journal:  Clin Microbiol Rev       Date:  1995-01       Impact factor: 26.132

5.  Immune mechanisms and protective antigens of Vibrio cholerae serogroup O139 as a basis for vaccine development.

Authors:  G Jonson; J Osek; A M Svennerholm; J Holmgren
Journal:  Infect Immun       Date:  1996-09       Impact factor: 3.441

Review 6.  Cholera toxin - a foe & a friend.

Authors:  Joaquin Sanchez; Jan Holmgren
Journal:  Indian J Med Res       Date:  2011-02       Impact factor: 2.375

7.  Analysis of expression of toxin-coregulated pili in classical and El Tor Vibrio cholerae O1 in vitro and in vivo.

Authors:  G Jonson; J Holmgren; A M Svennerholm
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

8.  Acquisition of classical CTX prophage from Vibrio cholerae O141 by El Tor strains aided by lytic phages and chitin-induced competence.

Authors:  S M Nashir Udden; M Shamim Hasan Zahid; Kuntal Biswas; Qazi Shafi Ahmad; Alejandro Cravioto; G Balakrish Nair; John J Mekalanos; Shah M Faruque
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-08       Impact factor: 11.205

9.  Vibrio cholerae non-O1 serogroup associated with cholera gravis genetically and physiologically resembles O1 E1 Tor cholera strains.

Authors:  R H Hall; F M Khambaty; M H Kothary; S P Keasler; B D Tall
Journal:  Infect Immun       Date:  1994-09       Impact factor: 3.441

10.  Immunization with cholera toxin B subunit induces high-level protection in the suckling mouse model of cholera.

Authors:  Gregory A Price; Kim McFann; Randall K Holmes
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.